ANGLE plc (LON:AGL – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.26 ($0.14) and traded as low as GBX 10.50 ($0.13). ANGLE shares last traded at GBX 11.22 ($0.14), with a volume of 865,932 shares traded.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reissued a “buy” rating and set a GBX 70 ($0.85) target price on shares of ANGLE in a research report on Thursday, September 26th.
Read Our Latest Analysis on ANGLE
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Articles
- Five stocks we like better than ANGLE
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What is the FTSE 100 index?
- Oilfield Leader SLB: An AI Name You Need to Know
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.